We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Lens Method Analyzes Tears for Early Disease Detection

By LabMedica International staff writers
Posted on 20 Dec 2024

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. More...

The presence of specific proteins in these biofluids can be a sign of health issues. Tears, in particular, are well-suited for detecting eye diseases such as glaucoma and macular degeneration, but they can also help identify systemic conditions like breast cancer and Alzheimer's disease. The challenge, however, is that collecting tears is difficult. Existing tear sampling methods can be uncomfortable, irritating to the eye, and typically yield reflex tears, which are less useful for disease detection. Now, researchers have developed an innovative technique using soft contact lenses to collect proteins from basal tears, offering a more efficient method for early disease detection.

While reflex tears are easily triggered by irritation, they are unlikely to contain the proteins needed for disease detection. These tears would dilute the indicator proteins that could point to a health issue. To avoid this, researchers at Brigham Young University (Provo, UT, USA) proposed a gentler approach: using soft contact lenses that naturally absorb proteins from the eye. Their tests showed that lenses made from the hydrogel material Etafilcon-A collected the highest protein levels without causing irritation.

In experiments, volunteers wore the contact lenses for just five minutes, and the lenses absorbed nearly the same range of proteins as traditional methods, but with significantly less discomfort. This new approach, as described in the study published in Clinical Proteomics, also allows patients to collect their own tears, removing the need for a trained optometrist. The research team is currently conducting further clinical trials to link specific tear proteins with diseases like macular degeneration and cancer. Their long-term goal is to make this method available in optometrists' and oncologists' offices, providing an easy and non-invasive way to detect early signs of various conditions.

“How many people could be helped if doctors could catch diseases before symptoms develop? With this new lens method, we could potentially screen for a range of health issues from analyzing tears,” said former grad student Robert Roden. “This project is very powerful in its scope. Any disease that your blood touches has the potential to show up in your tears. Hopefully this sampling can turn into a routine screening.”


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.